Home | Noventure

Noventure licenses innovative, substance-based medical devices in Gastroenterology, Urogynecology, Pediatrics and Dermatology and specialized food supplements.

We establish long term licensing agreements through an extensive network of partners and distributors in 45 countries.

Noventure is ISO 13485 certified and our medical devices bear the СЄ marking.

Our innovative, substance-based medical devices are a friendlier and effective solution for the patient. They have no pharmacological, metabolic, or chemical effect, and they respect physiological functions.

Our specialized food supplements come in distinctive galenics, thereby increasing acceptability, adherence, and consumer experience.

Our products reach patients in more than 50 countries worldwide

View map

Let's meet in ...

2025, Mar 21

EAU 2025

Noventure will attend the EAU 2025 to be held in Madrid, Spain, 21-24 March 2025.

Arrange a meeting with us to learn more about our products and license availability in the different countries. Meet us at our Stand!

2025, Mar 26

EWMA 2025

Noventure will attend the EWMA 2025 to be held in Barcelona, 26-28 March 2025

Arrange a meeting with us to learn more about our products and license availability in the different countries. Meet us at our Stand!
Contact us: https://noventure.com/contact-us

2025, May 14

ESPGHAN 2025

Noventure will attend the 57th Annual Meeting of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN), taking place in Helsinki, Finland, from May 14th to 17th, 2024

Arrange a meeting with us to learn more about our products and license availability in the different countries.

Meet us at our Stand #10!

Noventure at a glance

Our Partnering-out Model

Our Innovation Partnering Model

Our portfolio

Our products reach patients in more than 50 countries worldwide

Let's meet in ...